Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) [NA]
A completed clinical trial investigating postprandial fatty acids and FABP2 in individuals with Type 2 Diabetes Mellitus (with dyslipidemia)…
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port [NA]
A prospective randomized parallel crossover study evaluated the wearability and usability of the I-Port Injection Port in individuals with T…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study of the Effects of Vitamin C on Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial evaluating vitamin C (ascorbic acid) in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes
A completed clinical trial evaluating the health effects of liposuction in overweight women with elevated insulin levels, impaired glucose t…
-
CLINICAL_TRIALS trial_result · 2008-03-03Clinical Trial Update: Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes [NA]
A Hospices Civils de Lyon-sponsored clinical trial evaluating whether myocardial ischemia assessment is needed in patients with Type 2 diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-02-29FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for metformin hydrochloride (Mylan Pharmaceuticals Inc.) to update/expand labeling for the product.
-
FDA approval · 2008-02-26FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2008-02-25Clinical Trial Update: Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes [Phase 1]
Completed Phase 1 study evaluating the effect of a high monounsaturated fat diet on glycemic control and cardiovascular risk factors in indi…
-
CLINICAL_TRIALS trial_result · 2008-02-22Clinical Trial Update: A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]
DiObex sponsored a Phase 1/2a trial of the 2S,4R enantiomer of ketoconazole in Type 2 diabetes mellitus. The study has completed its Phase 1…
-
CLINICAL_TRIALS trial_result · 2008-02-14Clinical Trial Update: GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes [Phase 3]
Phase 3 trial of the GOAL lifestyle-change intervention to prevent Type 2 diabetes mellitus has completed. The study enrolled individuals wi…
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. [Phase 2]
Pfizer conducted a Phase 2 trial comparing inhaled insulin with subcutaneous insulin in people with Type 2 diabetes to assess effects on lun…
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: Near Normalisation of BG Improves the Potentiating Effect of GLP-1 [NA]
A completed clinical trial indicates that achieving near-normal blood glucose levels improves the potentiating effect of GLP-1 in type 2 dia…
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: Beta-Cell Function After Near-Normalisation of Blood Glucose [NA]
Clinical trial update describing beta-cell function after near-normalisation of blood glucose in individuals with Type 2 diabetes.
-
FDA approval · 2008-02-12FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Lifsa Drugs, LLC)
The FDA approved a supplemental application for Lifsa Drugs' metformin hydrochloride, a generic metformin product.
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: US Inhaled Insulin Dose Titration Study [Phase 3]
Pfizer's Phase 3 US dose-titration study of inhaled insulin in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-07Clinical Trial Update: Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes [Phase 4]
The Phase 4 trial compares pioglitazone with insulin glargine for patients with type 2 diabetes experiencing secondary drug failure; the stu…
-
CLINICAL_TRIALS trial_result · 2008-02-06Clinical Trial Update: Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment [Phase 2]
Phase 2 trial update on ISIS 113715 assessing safety, tolerability, and activity in people with Type 2 Diabetes Mellitus; the study has comp…
-
CLINICAL_TRIALS trial_result · 2008-01-31Clinical Trial Update: TTA in Treatment of Diabetes and Dyslipidemia [Phase 2]
Phase 2 trial of TTA for treatment of Type 2 Diabetes Mellitus and Dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-29Clinical Trial Update: A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus [Phase 4]
A Phase 4 clinical trial comparing the short-term efficacy and safety of Exubera and Lantus in adults with Type 2 diabetes has completed.
-
FDA approval · 2008-01-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for Metformin hydrochloride from Viona Pharmaceuticals Inc, indicating changes to an already app…
-
FDA approval · 2008-01-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for Metformin Hydrochloride (Viona Pharmaceuticals Inc), reflecting a change to the labeling under a…
-
EMA safety_alert · 2008-01-24EMEA recommends new warnings and contraindications for rosiglitazone
The European Medicines Agency recommends new warnings and contraindications for rosiglitazone to address cardiovascular and other risks.
-
FDA approval · 2008-01-18FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2008-01-11FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2008-01-09Clinical Trial Update: Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes [Phase 3]
Completed Phase 3 long-term study evaluating WelChol as add-on therapy for patients with Type 2 diabetes, focusing on safety and efficacy.